Final Program

MONDAY • MAY 16 205
CC2
CLINICAL
ADULT CLINICAL CORE CURRICULUM
CME Credits Available: 1.5
SLEEP MEDICINE CLINICAL CORE CURRICULUM I
Adult Core Curriculum Working Group
11:45 a.m. - 1:15 p.m. MOSCONE CENTER
Gateway Ballroom 102-104 (South Building, Lower Level)
Target Audience
Internists and subspecialists in pulmonary, critical care, and sleep medicine
who work in a clinical setting and are currently engaged in maintenance of
certification.
Objectives
At the conclusion of this session, the participant will be able to:
• remain current with medical knowledge relevant to their practice in
pulmonary, critical care, and sleep medicine;
• evaluate their understanding of key skills and content areas in pulmonary,
critical care and sleep medicine, as well as receive feedback on their
comprehension of a result of a pre-test/post-test comparison;
• support clinicians who are engaged in maintenance of certification activities
by providing updates on subjects included in recertification requirements.
The ATS Clinical Core Curriculum Symposia focus on a 3-year content cycle of
key medical content in the areas of pulmonary, critical care, and sleep medicine.
The topics are also aligned with corresponding MOC Medical Knowledge
modules. This symposium is intended to assist clinicians with staying current
with the growth of information relevant to their medical practice, as well as
provide an opportunity to evaluate individual knowledge and skills while earning
MOC Medical Knowledge points.
Chairing: J.S. Balachandran, MD, Chicago, IL
T.S. Wang, MD, Los Angeles, CA
11:45 Sleep Testing/Staging/Scoring: Staging and Scoring
C. Lal, MD, Charleston, SC
12:05 Sleep Testing/Staging/Scoring: In-Lab Diagnostics
N.A. Shah, MD, MPH, New York, NY
12:45 Sleep Testing/Staging/Scoring: Ambulatory Diagnostics
K.F. Sarmiento, MD, MPH, La Jolla, CA
L11
CENTER FOR TOBACCO PRODUCTS,
U.S. FOOD AND DRUG ADMINISTRATION
FDA REGULATION OF TOBACCO PRODUCTS IN
THE U.S.: 2016 UPDATE
12:15 p.m. - 1:15 p.m. MOSCONE CENTER
Room 3016/3018 (West Building, Level 3)
Target Audience
Any attendees interested in reducing tobacco related deaths.
Objectives
At the conclusion of this session, the participant will be able to:
• understand the FDA’s Center for Tobacco Products’ (CTP) strategic
priorities and CTP’s vision for the regulation of tobacco products to help
reduce the death and disease toll caused by tobacco use;
• discuss the Deeming Proposed Rule and how it will affect the way CTP
evaluates the newly regulated products;
• understand CTP’s research portfolio and how the Office of Science uses
this information to inform tobacco product regulation.
The 2009 Tobacco Control Act gave FDA regulatory authority over cigarettes,
cigarette tobacco, roll-your-own tobacco, and smokeless tobacco. Newly
“deemed” products in a proposed rule include electronic cigarettes, cigars, pipe
tobacco, certain dissolvables that are not “smokeless tobacco,” gels, and
waterpipe tobacco. Once the proposed rule becomes final, FDA will be able to
use regulatory tools, such as age restrictions and rigorous scientific review of
new tobacco products and claims to reduce tobacco-related disease and death.
Youth use of certain unregulated tobacco products, such as e-cigarettes and
cigars, is on the rise. FDA oversight of tobacco products can provide important
information about proposed deemed tobacco products and help limit youth
exposure to these products. Once final, the rule will also enable FDA to explore
whether different products pose different levels of risk, and will help the Agency
develop policies to improve public health. This session will help the medical,
research, and public health communities understand the authority granted to the
FDA to regulate tobacco and tobacco products and how science is used to
make the most effective regulatory decisions.
Chairing: P. Callahan-Lyon, MD, Silver Spring, MD
12:15 FDA Regulation of Tobacco Products in the U.S.
P. Callahan-Lyon, MD, Silver Spring, MD
12:55 CTP Research Portfolio
C. Dresler, MD, Silver Spring, MD
L12
NATIONAL AERONAUTICS AND
SPACE ADMINISTRATION
NASA’S SATELLITES AND MODELS TO STUDY
THE ENVIRONMENT AND DISEASES
12:15 p.m. - 1:15 p.m. MOSCONE CENTER
Room 3010/3012 (West Building, Level 3)
Target Audience
Pulmonary health researchers and clinicians needing environmental data to
study and understand the geographic, environmental, and meteorological
differences in pulmonary disease. The researcher will hear from public health
researchers new research and models that can be used to study the
environment and related diseases.
Objectives
At the conclusion of this session, the participant will be able to:
• inform clinicians and researchers about ongoing NASA projects related to lung
performance and cardiac disease;
• provide a synopsis of a project using observations of earth’s environment and public
health applications that are of interest to pulmonary clinicians and researchers;
• provide an overview of the NASA Health and Air Quality Program relating to public
health applications that are of interest to pulmonary clinicians and researchers.
MONDAY MID-DAY
ATS 2016 • San Francisco